Botox or the new face of the fight against depression - literature review

<p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 114%;" align="justify"><strong><span style="font-family: 'Times New Roman'; line-height: 114%;">Introduction:</span></strong>&l...

Full description

Bibliographic Details
Main Authors: Martyna Nowińska, Magdalena Kozyra, Przemysław Raczkiewicz, Marlena Kaczerska, Natalia Śmiech, Joanna Milanowska
Format: Article
Language:English
Published: Kazimierz Wielki University 2021-08-01
Series:Journal of Education, Health and Sport
Subjects:
Online Access:https://apcz.umk.pl/czasopisma/index.php/JEHS/article/view/35039
_version_ 1818588835482697728
author Martyna Nowińska
Magdalena Kozyra
Przemysław Raczkiewicz
Marlena Kaczerska
Natalia Śmiech
Joanna Milanowska
author_facet Martyna Nowińska
Magdalena Kozyra
Przemysław Raczkiewicz
Marlena Kaczerska
Natalia Śmiech
Joanna Milanowska
author_sort Martyna Nowińska
collection DOAJ
description <p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 114%;" align="justify"><strong><span style="font-family: 'Times New Roman'; line-height: 114%;">Introduction:</span></strong><span style="mso-spacerun: 'yes'; font-family: 'Times New Roman'; mso-fareast-font-family: Arial; line-height: 114%; font-size: 12,0000pt;"> Depression is a common psychiatric disorder leading to high burden especially for some other psychiatric comorbidity. Annually over 43 billion dollars are expended for patients with depression among them 28% are directly for depression and other costs are related to mortality and morbidity due to depression. </span></p><p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 114%;" align="justify"><strong><span style="font-family: 'Times New Roman'; line-height: 114%;">The aim of the study: </span></strong><span style="mso-spacerun: 'yes'; font-family: 'Times New Roman'; mso-fareast-font-family: Arial; line-height: 114%; font-size: 12,0000pt;">Paying attention to new options for treating depression – a disease that affects more and more people.</span></p><p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 114%;" align="justify"><strong><span style="font-family: 'Times New Roman'; line-height: 114%;">Material and method: </span></strong><span style="mso-spacerun: 'yes'; font-family: 'Times New Roman'; mso-fareast-font-family: Arial; line-height: 114%; font-size: 12,0000pt;">The research was done by the usage of the PubMed and Google Scholar articles about the topic of: botulinum toxin; depression; treatment.</span></p><p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 114%;" align="justify"><strong><span style="font-family: 'Times New Roman'; line-height: 114%;">Description of the state of knowledge: </span></strong><span style="mso-spacerun: 'yes'; font-family: 'Times New Roman'; mso-fareast-font-family: Arial; line-height: 114%; font-size: 12,0000pt;">Injecting Botox into the muscles responsible for expression of anguish or sadness may potentially decrease the patients experience of feelings. Botox reversibly blocks acetylcholine release from neuronal axons into the synapse, inhibiting neuromuscular transmission. If the facial feedback hypothesis is correct, by injecting Botox into the corrugator and procerus muscles, it will reversibly inhibit frown facial expressions and have the capability of propagating or enhancing sad and depressed feelings.</span></p><p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 114%;" align="justify"><strong><span style="font-family: 'Times New Roman'; line-height: 114%;">Summary</span></strong><span style="mso-spacerun: 'yes'; font-family: 'Times New Roman'; mso-fareast-font-family: Arial; line-height: 114%; font-size: 12,0000pt;">: The results from all randomized control trials proved that botulinum toxin A injection in the glabellar region was associated with significant improvement mood and may be a s</span><span style="font-family: 'Times New Roman'; line-height: 114%;">afe and effective treatment to reduce symptoms of depression.</span></p>
first_indexed 2024-12-16T09:31:04Z
format Article
id doaj.art-5958310078b44e84acc2598e3ed676bb
institution Directory Open Access Journal
issn 2391-8306
language English
last_indexed 2024-12-16T09:31:04Z
publishDate 2021-08-01
publisher Kazimierz Wielki University
record_format Article
series Journal of Education, Health and Sport
spelling doaj.art-5958310078b44e84acc2598e3ed676bb2022-12-21T22:36:31ZengKazimierz Wielki UniversityJournal of Education, Health and Sport2391-83062021-08-0111826827510.12775/JEHS.2021.11.08.02827771Botox or the new face of the fight against depression - literature reviewMartyna Nowińska0Magdalena Kozyra1Przemysław Raczkiewicz2Marlena Kaczerska3Natalia Śmiech4Joanna Milanowska5Student Research Group of Applied Psychology, Medical University of LublinStudent Research Group of Applied Psychology, Medical University of LublinStudent Research Group of Applied Psychology, Medical University of LublinStudent Research Group of Applied Psychology, Medical University of LublinStudent Research Group of Applied Psychology, Medical University of LublinDepartment of Applied Psychology, Medical University of Lublin<p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 114%;" align="justify"><strong><span style="font-family: 'Times New Roman'; line-height: 114%;">Introduction:</span></strong><span style="mso-spacerun: 'yes'; font-family: 'Times New Roman'; mso-fareast-font-family: Arial; line-height: 114%; font-size: 12,0000pt;"> Depression is a common psychiatric disorder leading to high burden especially for some other psychiatric comorbidity. Annually over 43 billion dollars are expended for patients with depression among them 28% are directly for depression and other costs are related to mortality and morbidity due to depression. </span></p><p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 114%;" align="justify"><strong><span style="font-family: 'Times New Roman'; line-height: 114%;">The aim of the study: </span></strong><span style="mso-spacerun: 'yes'; font-family: 'Times New Roman'; mso-fareast-font-family: Arial; line-height: 114%; font-size: 12,0000pt;">Paying attention to new options for treating depression – a disease that affects more and more people.</span></p><p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 114%;" align="justify"><strong><span style="font-family: 'Times New Roman'; line-height: 114%;">Material and method: </span></strong><span style="mso-spacerun: 'yes'; font-family: 'Times New Roman'; mso-fareast-font-family: Arial; line-height: 114%; font-size: 12,0000pt;">The research was done by the usage of the PubMed and Google Scholar articles about the topic of: botulinum toxin; depression; treatment.</span></p><p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 114%;" align="justify"><strong><span style="font-family: 'Times New Roman'; line-height: 114%;">Description of the state of knowledge: </span></strong><span style="mso-spacerun: 'yes'; font-family: 'Times New Roman'; mso-fareast-font-family: Arial; line-height: 114%; font-size: 12,0000pt;">Injecting Botox into the muscles responsible for expression of anguish or sadness may potentially decrease the patients experience of feelings. Botox reversibly blocks acetylcholine release from neuronal axons into the synapse, inhibiting neuromuscular transmission. If the facial feedback hypothesis is correct, by injecting Botox into the corrugator and procerus muscles, it will reversibly inhibit frown facial expressions and have the capability of propagating or enhancing sad and depressed feelings.</span></p><p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 114%;" align="justify"><strong><span style="font-family: 'Times New Roman'; line-height: 114%;">Summary</span></strong><span style="mso-spacerun: 'yes'; font-family: 'Times New Roman'; mso-fareast-font-family: Arial; line-height: 114%; font-size: 12,0000pt;">: The results from all randomized control trials proved that botulinum toxin A injection in the glabellar region was associated with significant improvement mood and may be a s</span><span style="font-family: 'Times New Roman'; line-height: 114%;">afe and effective treatment to reduce symptoms of depression.</span></p>https://apcz.umk.pl/czasopisma/index.php/JEHS/article/view/35039botulinum toxindepressiontreatment
spellingShingle Martyna Nowińska
Magdalena Kozyra
Przemysław Raczkiewicz
Marlena Kaczerska
Natalia Śmiech
Joanna Milanowska
Botox or the new face of the fight against depression - literature review
Journal of Education, Health and Sport
botulinum toxin
depression
treatment
title Botox or the new face of the fight against depression - literature review
title_full Botox or the new face of the fight against depression - literature review
title_fullStr Botox or the new face of the fight against depression - literature review
title_full_unstemmed Botox or the new face of the fight against depression - literature review
title_short Botox or the new face of the fight against depression - literature review
title_sort botox or the new face of the fight against depression literature review
topic botulinum toxin
depression
treatment
url https://apcz.umk.pl/czasopisma/index.php/JEHS/article/view/35039
work_keys_str_mv AT martynanowinska botoxorthenewfaceofthefightagainstdepressionliteraturereview
AT magdalenakozyra botoxorthenewfaceofthefightagainstdepressionliteraturereview
AT przemysławraczkiewicz botoxorthenewfaceofthefightagainstdepressionliteraturereview
AT marlenakaczerska botoxorthenewfaceofthefightagainstdepressionliteraturereview
AT nataliasmiech botoxorthenewfaceofthefightagainstdepressionliteraturereview
AT joannamilanowska botoxorthenewfaceofthefightagainstdepressionliteraturereview